Gaddis' study posit that elevating Apo-AI levels in humans may favorably regulate the balance between Tfh cell generation and T regulatory (Treg) cell maintenance, ultimately contributing to the mitigation of inflammation, plaque accumulation, and the progression of atherosclerosis.13 The gene discussed is APOA1; the disease is atherosclerosis.